Kalata B7

General Information


DRACP ID  DRACP03484

Peptide Name   Kalata B7

Sequence  GLPVCGETCTLGTCYTQGCTCSWPICKRN

Sequence Length  29

UniProt ID  B6E619  P58457 

PubChem CID  Not available

Origin  Synthetic

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  2M9O 

Predicted Structure  DRACP03484

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C128H204N36O41S6

Absent amino acids  ADFHM

Common amino acids  C

Mass  359523

Pl  7.73

Basic residues  2

Acidic residues  1

Hydrophobic residues  5

Net charge  1

Boman Index  -2328

Hydrophobicity  3.79

Aliphatic Index  50.34

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  7365

Absorbance 280nm  263.04

Polar residues  18

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18618891

Title  The anthelmintic activity of the cyclotides: natural variants with enhanced activity

Doi Not available

Year  2008

Literature 2

Pubmed ID 28669767

Title  Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra

Doi Not available

Year  2017

Literature 3

Pubmed ID 20564013

Title  Structural and biochemical characteristics of the cyclotide kalata B5 from Oldenlandia affinis

Doi Not available

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  5238

DRACP is developed by Dr.Zheng's team.